Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Clinical trial NCT01605708 · TERMINATED
Trial details
- NCT number
- NCT01605708
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-04-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.